Altre lingue Pangenomic Health Inc.

Azioni

NARA

CA69842E3041

Mercato chiuso - Canadian Securities Exchange Altri mercati azionari 19:14:10 25/06/2024			Variaz. 5gg	Var. 1 gen.
0,1 ^CAD	+33,33%		-.--%	-50,00%

16/02	Pangenomic Health Inc. annuncia cambiamenti nel Consiglio di Amministrazione	CI
2023	Pangenomic Health Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Canadian Investment Regulatory Organization Trading Halt - NARA	04/07
PanGenomic Health Provides Update on Management Cease Trade Order	29/05
Pangenomic Health Inc. announced that it has received CAD 1.075116 million in funding	27/05
Pangenomic Health Inc. announced that it expects to receive CAD 1 million in funding	17/05
PanGenomic Health Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements	13/04
PanGenomic Health Announces Completion of Consolidation	21/03
CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)	19/03
PanGenomic Health Announces Proposed Consolidation and Completion of Withdrawal from AQSE	18/03
PanGenomic Health Announces Withdrawal from AQSE	20/02
PanGenomic Health plans to withdraw shares from Aquis Stock Exchange	19/02
PanGenomic Health Announces Changes to Board of Directors	16/02
Pangenomic Health Inc. Announces Changes to Board of Directors	16/02
PanGenomic Health agrees non-binding drawdown facility with Crescita	09/01
PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility	09/01
PanGenomic subsidiary reveals point-of-care vitamin D test	06/12
PanGenomic Health Subsidiary Introducing Point-of-Care Vitamin D Test for Dental Implant Industry	06/12
PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry	06/12
Pangenomic Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way	22/11
PanGenomic Health's MUJN sells first biomarker tests	17/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Pangenomic Health Inc.

Azioni

NARA

CA69842E3041

Altre lingue

Filtri